Having trouble viewing this email? View it your browser.
|
|
TRANSLATIONAL
REGENERATIVE
MEDICINE FORUM
APRIL 6–8, 2010 • TWIN CITY QUARTER • WINSTON-SALEM, NORTH CAROLINA
|
|
|
| |
 |
Dear colleagues and friends,
I would like to invite you to attend the inaugural Translational Regenerative Medicine Forum, which will take place April 6-8, 2010, in Winston-Salem, North Carolina. Produced by the Regenerative Medicine Foundation, this meeting is the first of its kind to convene leaders from academic, research, clinical, regulatory, government, reimbursement and biotechnology industry interests.
Regenerative Medicine has been called "the new frontier in health care for the 21st century". |
The promise of personalized medicine using various therapies, including stem cells, small molecules, engineered tissues, and smart biomaterials, is now becoming a reality. The Regenerative Medicine Forum will provide the opportunity for individuals involved in this field to interact at all levels, from bench research, to the clinical deliverables and beyond. |
I encourage you to register to be a part of this event.
Warm Regards,
Anthony Atala, M.D. |
|
|
| |
*SPEAKERS
|
B. Lynn Allen-Hoffmann, PhD
CEO, President, CSO
Stratatech Corporation
Mostafa Analoui, PhD
Senior Advisor and Head of Healthcare and Life Sciences
The Livingston Group
Anthony Atala, MD
Director
Wake Forest Institute for Regenerative Medicine
Steven Bauer, PhD
Chief, Cell and Tissue Therapy Branch
FDA Center for Biologics Evaluation and Research
Tim Bertram, DVM, PhD
Senior Vice President
Science and Technology
Tengion
Rick Blume
Managing Director
Excel Venture Management
Robert P. Brady
Partner
Hogan & Hartson, LLP
R. Lee Buckler, BEd, LLB
Founder, Managing Director,
Principal Consultant
Cell Therapy Group
Scott R. Burger, MD
Principal
Advanced Cell & Gene Therapy
Anthony Caggiano, MD, PhD
Vice President, Clinical Development
Acorda Therapeutics
Richard E. Caruso, PhD
Founder and Chairman of the Board
Integra
Tim Coetzee, PhD
President
Fast Forward
Ray Cypess, PhD
CEO
ATCC
Allen Davidoff, PhD
VP, Product Development
Stem Cell Therapeutics Corp. |
Robert Deans, PhD
Senior Vice President
Regenerative Medicine, Athersys
Mime Egani, PhD
Visiting Professor, Institute of Advanced Biomedical Engineering and Science
Tokyo Women’s Medical University
Juan Enriquez
Managing Director
Excel Venture Management
Ed Field
President and CEO
Aldagen
Joydeep Goswami, PhD, MBA
Vice President and General Manager
Primary and Stem Cell Systems
Life Technologies
Col. Janet R. Harris, PhD, MSN
US Army Nurse Corps Director
Congressionally Directed Medical Research Programs
Jeff Karan, MBA
Senior Partner
Proteus Ventures Partners
Jack A. Kessler, MD
Director, Feinberg Neuroscience Institute
Northwestern University
Robert Klein
Chairman, ICOC
California Institute for Regenerative Medicine
Lynnet Koh, MBA
Founder and CEO
America Stem Cell Inc.
Garheng Kong, MD, PhD
General Partner
Intersouth Partners
Gary J. Kurtzman, MD
Vice President and Managing Director
Life Sciences Group
Safeguard Scientifics
Robert Lanza, MD
Chief Scientific Officer
Advanced Cell Therapy
|
Alan J. Lewis, PhD
President and CEO
Juvenile Diabetes Research Foundation
Scott Livingston
Chairman and CEO
Livingston Securities LLC
Douglas Losordo, MD, FACC
Professor of Medicine
Northwestern University School of Medicine
Geoff MacKay
President and CEO
Organogenesis
Michelle McMurry-Heath, MD, PhD
Director, Health, Biomedical Science and Society Initiative
The Aspen Institute
Stephen Minger, PhD
Director of R&D for Cell Technologies
GE Healthcare
Lesa Mitchell
Vice President
Kauffman Foundation
Leslie Molony, PhD
CEO
Transgeneron
Gail K. Naughton, PhD
CEO
Histogen
P. Sherrill Neff
Founding Partner
Quaker BioVentures
Professor Teruo Okano, PhD
Director of the Institute of Advanced Biomedical Engineering and Science
Tokyo Women’s Medical University
Buddy D. Ratner, PhD
Director
University of Washington
Engineered Biomaterials
Brock Reeve, MPhil, MBA
Executive Director
Harvard Stem Cell Institute
|
Camillo Ricordi, MD
Diabetes Research Institute
University of Miami, Miller School of Medicine
Vincent Ronfard, PhD
Vice President of Research
Organogenesis
Edmund “Morrie” Ruffin, MA
Managing Director
Adjuvant Global Advisors
Lieutenant General
Eric B. Schoomaker, MD, PhD
The Surgeon General/Commander
US Army Medical Command
Bernard Siegel
Founder and Executive Director
Genetics Policy Institute
G. Sitta Sittampalam, PhD
Director, The Institute for Advancing
Medical Innovation
University of Kansas
Dean Tozer
Senior Vice President
Advanced BioHealing
Col. Robert Vandre, DDS
Research Area Director
US Army, Medical Research and
Materiel Command
Andrew von Eschenbach, MD
Greenleaf Health LLC and Center for Health Transformation
Former US FDA Commissioner
John Walker
CEO
iPierian
Jay Watkins
Managing Director
De Novo Ventures
Scott Weir, PharmD, PhD
Director, Institute for Advancing
Medical Innovation
University of Kansas
Michael J. Werner
Partner, Public Policy Group
Holland & Knight |
* Confirmed as of January 1, 2010.
Please see website for full information. |
|
|
|
|
| |
THE TRANSLATIONAL REGENERATIVE MEDICINE FORUM |
|
• A premiere international event held annually in Winston-Salem, North Carolina
• Dedicated to advancing the field of regenerative medicine and healthcare innovation
• Featuring keynote speakers and panelists sharing scientific discoveries, business models, and best practices
• Opportunity to network with attendees representing academic and clinical research, biotechnology, healthcare policy,
regulatory, reimbursement, and venture investment |
|
AGENDA
|
|
Tuesday, April 6, 2010
4:00–6:00 pm Conference Registration and Network
6:00–7:30 pm Opening Reception |
Wednesday, April 7, 2010
7:30–8:30 am Networking Breakfast
8:30–8:45 am Welcome and Opening Remarks
Welcome Anthony Atala, MD, Wake Forest Institute for Regenerative Medicine
Special Guest TBA
Special Guest Patient Perspective
8:45–9:15 am What Is the Promise of Regenerative Medicine?
Moderator John E. Abele, Founding Chairman, Retired, Boston Scientific Corporation
Panelist Alan J. Lewis, PhD, Juvenile Diabetes Research Foundation International
Panelist Andrew von Eschenbach, MD, Greenleaf Health LLC and Center for Health Transformation, Former US FDA Commissioner
Panelist John Walker, iPierian
Panelist Gary J. Kurtzman, MD, Safeguard Scientifics
9:15–10:00 am The Translational Imperative: Deliver the Promise
Moderator Lesa Mitchell,
Kauffman Foundation
Panelist Brock Reeve, MPhil, MBA,Harvard Stem Cell Institute
Panelist Scott Weir, PharmD, PhD, University of Kansas, Institute for Advancing Medical Innovation
Panelist Rick Blume, Excel Medical Ventures
10:00–10:30 am Networking Break
10:30–11:15 am The Science: What’s Next for the Clinic?
Keynote Address Robert Lanza, Advanced Cell Technology
Panelist Bernard Siegel, Genetics Policy Institute
Panelist COL Janet R. Harris, PhD, MSN, AFIRM Congressionally Directed Medical Research Programs
Panelist DaLaura L.S. Kader, Regenerative Medicine Foundation
Panelist Michelle McMurry-Heath, MD, PhD, The Aspen Institute
11:15 am–noon Bridging: From the Bench to the Bedside
Moderator Michael Werner, Holland & Knight
Panelist Bernard Siegel, Genetics Policy Institute
Panelist COL Janet R. Harris, PhD, MSN, AFIRM Congressionally Directed Medical Research Programs
Panelist DaLaura L.S. Kader, Regenerative Medicine Foundation
Panelist Michelle McMurry-Heath, MD, PhD, The Aspen Institute
Panelist Rosemarie Hunziker, PhD, National Institute of Biomedical Imaging and Bioengineering, National Institutes of Health
NOON–12:30 pm Lunch
12:30–1:15 pm A Funding Model for Translational Medicine
Keynote Address Bob Klein, California Institute for Regenerative Medicine
1:15–2:00 pm Integrative Commercialization Strategies
Moderator Scott Burger, Advanced Cell & Gene Therapy
Panelist Stephen Minger, PhD, GE Healthcare
Panelist Steven R. Bauer, PhD, US Food and Drug Administration
Panelist Vincent Ronfard, PhD, Organogenesis
Panelist Joydeep Goswami, PhD, MBA, Life Technologies
Panelist Tim Bertram, DVM, PhD, Tengion
2:00–2:45 pm Regulatory and Reimbursement Strategies
ModeratorAndrew von Eschenbach, MD, Greenleaf Health LLC and Center for Health Transformation, Former US FDA Commissioner
Panelist Steven R. Bauer, PhD, US Food and Drug Administration
Panelist Anthony Ratcliffe, PhD, Synthasome
Panelist Robert P. Brady, Hogan & Hartson
Panelist Richard E. Caruso, PhD, Integra
2:45–3:15 pm International Best Practices in Regenerative Medicine
Moderator David Williams
Panelist Prof. Chunren Wang, National Institute for the Control of Pharmaceutical and Biological Products
Panelist COL Robert Vandre, DDS, AFIRM
Panelist Mime Egami, PhD, Tokyo Women’s Medical University
3:15–3:35 pm Networking Break
3:35–5:30 pm Scientific Discovery
3:35–4:45 pm
Host and Presenter Buddy Ratner, University of Washington
Presenter Teruo Okano, PhD, Tokyo Women’s Medical University
Presenter Jennifer H. Elisseeff, PhD, Johns Hopkins University
Presenter Jack Kessler, MD, Northwestern University
Presenter G. Sitta Sittampalam, PhD,
University of Kansas, Institute for Advancing Medical Innovation
Presenter Douglas Losordo, MD, FACC, Northwestern University
Presenter Camillo Ricordi, MD, Diabetes Research Institute, University of Miami Miller School of Medicine
Presenter Simon Cool, PhD, A*STAR Singapore
Presenter B. Lynn Allen-Hoffmann, PhD,
Stratatech Corporation
Presenter Yilin Cao, MD, PhD,
Shanghai Jiao Tong University
4:45–5:30 pm
Presenter 1 Teruo Okano, PhD, Tokyo Women’s Medical University
Presenter 2 Jennifer Elisseeff, Johns Hopkins
Presenter 3 Jack Kessler, Northwestern
Presenter 4 Sitta Sittampalam, University of Kansas
Presenter 5 Douglas Losordo, Northwestern
Presenter 6 Camillo Ricordi, University of Miami
Presenter 7 Simon Cool, A*STAR Singapore
Presenter 8 Lynn Allen-Hoffmann,
Stratatech Corporation
Presenter 9 Yilin Cao, MD, PhD,
Shanghai Jiao Tong University
5:30–6:30 pm Networking Reception
7:00–8:30 pm Gala Dinner Keynote AddressJuan Enriquez, Excel Venture Management
|
Thursday, April 8, 2010
7:00–8:00 am Breakfast and Venture Forum I
Company Arterion
Company Articular Engineering
Company CDBI
Company ISTO Technologies
Company KeraNetics
Company Kryosphere
Company Southern Access Tech
Company Ventrix
8:00–8:30 am Regenerative Medicine and the U.S. Military
Keynote Gen. Eric Schoomaker, MD, PhD, US Army Medical Command
8:30–9:15 am Best Practices in Commercialization
Format: Panel
Moderator R. Lee Buckler, BEd, LLB,Cell Therapy Group
Panelist Anthony Caggiano, MD, PhD,
Acorda Therapeutics
Panelist Dean Tozer, Advanced BioHealing
Panelist Ed Field, Aldagen
Panelist Robert Deans, PhD, Athersys
Panelist Richard S. Stack, MD, FACC, Synecor
9:15–9:45 am Commercial Capacity and Tools
Moderator Morrie Ruffin, Adjuvant
Panelist Raymond H. Cypess, DVM, PhD, ATCC
Panelist Joseph DeSimone, PhD,
Liquidia Technologies
Panelist Kurt Last, Specialty Operations Solutions
Panelist David S. Smith,
Pepper Hamilton LLP
9:45–10:20 am Venture Panel I: Designing the Deal
Moderator Jeff Karan, MBA, Proteus Ventures
Panelist Garheng Kong, MD, PhD, Intersouth Partners
Panelist Frank Douglas, MD, PhD, Pure Tech Ventures, Austen BioInnovation Institute in Akron, Kauffman Foundation
Panelist Timothy Coetzee, PhD, Fast Forward
Panelist Mostafa Analoui, PhD, Livingston Group
Panelist Gail K. Naughton, PhD, Histogen
10:20–11:00 am Venture Panel II: Capturing Value for Capital Markets
Moderator Gary Kurtzman, Safeguard Scientifics
Panelist Jay Watkins, De Novo Ventures
Panelist Scott Livingston, Livingston Securities
Panelist Rick Blume, Excel Medical Ventures
Panelist P. Sherrill Neff, Quaker BioVentures
Panelist David Scheer, Scheer & Company
11:00–11:15 am Networking Break
11:15 am–12:55 pm Venture Forum II
Company ACell
Company America Stem Cell
Company Avita Medical
Company Axerion Therapeutics
Company Bioheart
Company Healionics
Company Juventas Therapeutics
Company Ocular Systems
Company PharmInova
Company Soft Tissue Regeneration
Company America Stem Cell
Company Transgeneron Therapeutics
12:55–1:00 pm Wrap Up and Adjourn Meeting
Anthony Atala, MD, Wake
Forest Institute for Regenerative Medicine |
| |
REGISTRATION |
|
 |
|
|
| Corporate Registration |
Academic/Not-for-Profit/Government |
$850.00 per attendee through March 15, 2010
$975.00 per attendee after March 15, 2010 and onsite |
$495.00 per attendee |
| |
|
| Registration costs include all conference materials, opening reception on Tuesday, April 6, breakfast, lunch, and dinner on Wednesday,
April 7, and breakfast and lunch on Thursday, April 8. For assistance registering for the Translational Regenerative Medicine Forum, please contact Sarahbeth Derrick via phone (336) 499-6765 or email: sarahbeth.derrick@aladdintravel.com |
|
| |
SPONSORSHIP OPPORTUNITIES AVAILABLE |
|
| |
|
| |
|
|
|
